Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chuanbei Qingfei Syrup is a traditional Chinese medicine (TCM) oral liquid manufactured by Juneng Golden Key Pharmaceutical (Wuhan Juneng Jinshi Pharmaceutical). It is an approved pharmaceutical product in China indicated for the treatment of respiratory conditions characterized by lung-heat, such as cough with yellow phlegm, dry throat, and sore throat. The formulation is a complex mixture of herbal extracts, typically including *Bulbus Fritillariae Cirrhosae* (Chuanbei), *Radix Platycodonis*, and *Folium Eriobotryae*, which work synergistically to clear heat, moistens the lungs, and facilitate expectoration. It is commonly used for acute and chronic bronchitis presenting with TCM-defined 'lung-heat' symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chuanbei Qingfei Syrup.